首页> 外国专利> GALECTIN-3 AND ANNEXIN-A2 AS IMMUNOLOGICAL TARGET

GALECTIN-3 AND ANNEXIN-A2 AS IMMUNOLOGICAL TARGET

机译:GALECTIN-3和Annexin-A2作为免疫目标

摘要

AmexinA2 (ANXA2), a member of the Annexin family of calcium-dependent, phospholipid binding proteins, is one of a panel of identified antigens recognized by the post-vaccination sera of patients who demonstrated prolonged disease-free survival following multiple vaccinations. AnnexinA2 is abundantly expressed in pancreatic adenocarcinomas and cell surface/membrane AnnexinA2 increases with the progression from premalignant lesions to invasive pancreatic adenocarcinomas. The cytoplasmic to cell surface translocation of AnnexinA2 expression is critical for pancreatic cancer cell invasion. In addition, phosphorylation of AnnexinA2 at Tyrosine 23 is important for its localization to the cell surface and for the invasion of pancreatic cancer cells. Finally, loss of AnnexinA2 leads to the loss of the Epithelial-Mesenchymal Transition.
机译:AmexinA2(ANXA2)是钙依赖性磷脂结合蛋白Annexin家族的成员,是一组在多次疫苗接种后表现出无病生存期的患者的疫苗接种后血清所识别的抗原之一。 AnnexinA2在胰腺腺癌中大量表达,细胞表面/膜AnnexinA2随着从癌前病变向侵袭性胰腺腺癌的发展而增加。 AnnexinA2表达的胞质向细胞表面移位对于胰腺癌细胞的侵袭至关重要。另外,在酪氨酸23上膜联蛋白A2的磷酸化对于其定位于细胞表面和侵袭胰腺癌细胞很重要。最后,膜联蛋白A2的丧失导致上皮-间充质转化的丧失。

著录项

  • 公开/公告号EP3115063A2

    专利类型

  • 公开/公告日2017-01-11

    原文格式PDF

  • 申请/专利权人 THE JOHN HOPKINS UNIVERSITY;

    申请/专利号EP20160182042

  • 申请日2009-12-02

  • 分类号A61K39/395;A61K38/16;A61K38/17;A61P35;C07K16/18;A61K39;A61K38;A61K38/19;C07K16/30;G01N33/68;G01N33/50;

  • 国家 EP

  • 入库时间 2022-08-21 14:04:12

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号